Skip to main content

The Over Diagnosis of Disease: How Medical Technology Can Endanger Your Health


Do you feel well?  If so, DO worry.  Emerging medical technology will soon fix that problem and cure you of your sense of well being.  Medical technology is advancing our ability to find more and more diseases.   Even if you feel well, advancing medical technology will soon find a disease with your name on it.  

It turns out that in a lot of people who think they are well, we can find pathological evidence of some disease process if we look hard enough.  And technology is improving our ability to look.  If you feel good, maybe we should just look harder and try to find something wrong.

This vision of medicine is not far fetched.  As a fascinating editorial in the Archives of Internal Medicine notes, this era is already upon us.  Authors Jerome Hoffman and Richelle Cooper write about how overdiagnosis of disease is becoming a modern epidemic.  It is created by medical technology and forced on an unsuspecting public that may not realized that more diagnosis can sometimes endanger their health.

The editorial notes another article in the Archives that described how better imaging technology is advancing our ability to diagnose pulmonary embolisms.  Pulmonary embolisms are blood clots that form in the lungs.  Previous technology tended to identify big embolisms that we knew to be life threatening.  But newer CT technology is identifying smaller embolisms.  But patients with small embolisms are treated with blood thinners in the same manner as patients with big embolisms.  It is not clear whether treating smaller and smaller embolisms will reduce mortality. 

We have previously discussed on GeriPal how this same issue may lead to overdiagnosis of Alzheimers disease.  Improving imaging and biomarker technologies can identify the pathologic changes of Alzheimers Disease decades before a person has any symptoms of dementia.  This can be good if treatments can prevent dementia. There is a big problem though.  Many of the persons with these pathologic changes will never have symptoms of Alzheimer’s disease.  They have pathology that is meaningless to them.  Yet, our new technologies risk subjecting them to treatments with possibly harmful side effects.

The problem is that better methods of diagnosis, such as advanced imaging techniques, is that they identify insignificant "diseases" that would have never been identified by old fashioned diagnostic methods.  The “pathologies” detected meet all standard definitions of diseases.  However, it turns out maybe it was actually good our old diagnostic technologies failed to identify these “diseases.” It turns out that these difficult to diagnose diseases may actually have little impact on the patient.  The patient feels no symptoms, and in many cases, if the diseases are not diagnosed, nothing bad will happen.

This actually turns what we learned about diagnostic testing in medical school on its head.  We learned that a diagnostic test can be either right or wrong.  We learned about these 4 outcomes of diagnostic testing:

  • 1       It can identify disease in someone has the disease (true positive)
  • 2       It can identify disease in someone who does not have disease (false positive)
  • 3       It can find no disease in someone who actually has disease (false negative)
  • 4       It can find no disease in someone who actually has no disease (true negative)
When we learned about these possibilities, the assumption was that the “truthful” outcomes were good, and the “false” outcomes were bad. 

We never considered the possibility that a test can accurately identify disease in a patient with a disease that does not matter.  We never learned about the blessed possibility that a test can fail to identify a disease in a patient who is better off not knowing about their meaningless "disease."

Maybe we need to change our definition of disease.  A disease should really be defined as a pathologic state that will lead to bad health outcomes in a patient.  Abnormal pathology that leads to no ill effects should not be defined as a disease.  Everything we know about diagnostic testing really needs to be reconfigured to account for this patient centered definition of disease. 

 
by: Ken Covinsky

Comments

Anonymous said…
thanks for sharing.
Anonymous said…
Ken, thanks for your superb commentary! I agree with your perspective and think that we doctors should be more cognizant of over-diagnosing. Your comments remind me of something one of my previous mentors (Dr. Alvan Feinstein) would have written or said. -sm
It seems most medical technologies these days overlook the old adage, "too much of a good thing is bad". While procedures have gotten so advanced that they've managed to detect "anomalies" that would've remained invisible twenty years ago, they might actually go as far as attack and neutralize some parts of those "anomalies" that might actually be beneficial to the body.

Popular posts from this blog

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …

Length of Stay in Nursing Homes at the End of Life

One out of every four of us will die while residing in a nursing home. For most of us, that stay in a nursing home will be brief, although this may depend upon social and demographic variables like our gender, net worth, and marital status. These are the conclusions of an important new study published in JAGS by Kelly and colleagues (many of whom are geripal contributors, including Alex Smith and Ken Covinsky).

The study authors used data from the Health and Retirement Study (HRS) to describe the lengths of stay of older adults who resided in nursing homes at the end of life. What they found was that out of the 8,433 study participants who died between 1992 and 2006, 27.3% of resided in a nursing home prior to their death. Most of these patients (70%) actually died in the nursing home without being transferred to another setting like a hospital.

 The length of stay data were striking:

the median length of stay in a nursing home before death was 5 months the average length of stay was l…

Palliative Care in Nursing Homes: Discussion of a Multinational Trial with Lieve Van den Block

Nursing homes are a tough place to do palliative care.  There is extremely high staff turnover, physicians are often not present except for the occasional monthly visit, many residents die with untreated symptoms usually after multiple hospitalizations and burdensome life-prolonging treatments, and specialty palliative care - well that is nowhere to be found in most nursing homes outside of hospice.  So what can we do to improve the palliative care outlook in nursing homes?

On todays podcast we talk with Lieve Van den Block about her recent palliative care intervention that was published in JAMA IM this week.  Lieve led a multicomponent intervention to integrate basic nonspecialist palliative care in in 78 nursing homes located in 7 different European countries.  Just take a moment to grasp the size of this study - 7 counties, 78 nursing homes.  I struggle with just trying to improve palliative care in one site!

We discuss with Lieve the results of the study, her take on why they got…